A Review of the Prevalence and Unmet Needs in the Management of Rheumatoid Arthritis in Africa and the Middle East Hani AlmoallimJamal Al SalehAyman El-Garf Review Open access 23 November 2020 Pages: 1 - 16
Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review Jose María Álvaro-GraciaJose Francisco García-LlorenteMaria Montoro Review Open access 27 November 2020 Pages: 17 - 40
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity Tom W. J. HuizingaYoshifumi ToriiRafael Muniz Review Open access 01 December 2020 Pages: 41 - 61
Renal Disease in Primary Sjögren’s Syndrome Oshorenua AiyegbusiLaura McGregorKathryn I. Stevens Review Open access 24 December 2020 Pages: 63 - 80
Antiphospholipid Antibodies in Inflammatory and Autoimmune Rheumatic and Musculoskeletal Diseases Beyond Lupus: A Systematic Review of the Available Evidence Georges El HasbaniMario ViolaImad Uthman Review Open access 09 January 2021 Pages: 81 - 94
Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study Pascal HilliquinThomas BarnetcheAlain Saraux Original Research Open access 20 November 2020 Pages: 95 - 108
Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations for Patients with Immune-Mediated Diseases in the United States Martin BergmanPankaj PatelChristopher D. Saffore Original Research Open access 21 November 2020 Pages: 109 - 118
Revascularization Versus Medical Therapy in Takayasu's Arteritis Patients with Coronary Artery Involvement Zhiwei HuangHongliang ZhangFenghuan Hu Original Research Open access 23 November 2020 Pages: 119 - 133
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial Atul DeodharPhilip MeaseVibeke Strand Original Research Open access 07 December 2020 Pages: 135 - 150
Single-Dose Intra-Articular Administration of a Hybrid Cooperative Complex of Sodium Hyaluronate and Sodium Chondroitin in the Treatment of Symptomatic Hip Osteoarthritis: A Single-Arm, Open-Label, Pilot Study Rocco PapaliaVincenzo SaliniCosimo Costantino Original Research Open access 27 November 2020 Pages: 151 - 165
A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis Christopher J. EdwardsRuta SawantKeith A. Betts Original Research Open access 26 November 2020 Pages: 167 - 181
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study Megan Francis-SedlakBrian LaMoreauxAlfonso E. Bello Original Research Open access 07 December 2020 Pages: 183 - 197
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2) Ana-Maria OrbaiJordi GratacósArnaud Constantin Original Research Open access 05 December 2020 Pages: 199 - 217
Salivary Glands and Periodontal Changes in a Population of Sjögren's and Sicca Syndrome Treated by Pilocarpine: A Pilot Study Thibaud DepinoyAlain SarauxSandrine Jousse-Joulin Original Research Open access 17 December 2020 Pages: 219 - 231
The Delay and Costs of Diagnosing Systemic Vasculitis in a Tertiary-Level Clinic Kirsi TaimenAnssi MustonenLaura Pirilä Original Research Open access 14 December 2020 Pages: 233 - 242
Features and Outcomes of Elderly Rheumatoid Arthritis: Does the Age of Onset Matter? A Comparative Study From a Single Center in China Yini KeXiaona DaiJin Lin Original Research Open access 14 December 2020 Pages: 243 - 254
Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy Junyu LiangChuanyin SunJin Lin Original Research Open access 28 December 2020 Pages: 255 - 272
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies Xenofon BaraliakosFilip Van den BoschAtul Deodhar Original Research Open access 22 December 2020 Pages: 273 - 288
How to Define Boolean Low Disease Activity in Rheumatoid Arthritis: Experience from a Large Real-world Cohort Wenhui XieGuangtao LiZhuoli Zhang Original Research Open access 23 December 2020 Pages: 289 - 301
Disease Burden and Costs in Moderate-to-Severe Chronic Osteoarthritis Pain Refractory to Standard of Care: Ancillary Analysis of the OPIOIDS Real-World Study Antoni Sicras-MainarJavier Rejas-GutierrezIsabel Lizarraga Original Research Open access 07 January 2021 Pages: 303 - 326
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis Kyle HayesMary P. PanaccioMohammed Fahim Original Research Open access 24 March 2021 Pages: 327 - 346
Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis Bon San KooYu-Cheol LimTae-Hwan Kim Original Research Open access 09 January 2021 Pages: 347 - 359
Safety and Efficacy of Prefilled Liquid Etanercept-Biosimilar Yisaipu for Active Ankylosing Spondylitis: A Multi-Center Phase III Trial Dongbao ZhaoDongyi HeFeng Huang Original Research Open access 09 February 2021 Pages: 361 - 374
The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization Andreas SchwartingHeiko FriedelEdward R. Hammond Original Research Open access 05 February 2021 Pages: 375 - 393
Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea So-Young HaYoon-Bo ShimMi-Hai Park Original Research Open access 26 January 2021 Pages: 395 - 409
Predictive Value of Active Sacroiliitis in MRI for Flare Among Chinese Patients with Axial Spondyloarthritis in Remission Qing ZhengWen LiuGuixiu Shi Original Research Open access 18 February 2021 Pages: 411 - 424
Safety and Effectiveness of Peficitinib (ASP015K) in Patients with Rheumatoid Arthritis: Final Results (32 Months of Mean Peficitinib Treatment) From a Long-Term, Open-Label Extension Study in Japan, Korea, and Taiwan Tsutomu TakeuchiYoshiya TanakaYuichiro Kaneko Original Research Open access 03 March 2021 Pages: 425 - 442
Persistence with Denosumab in Women at High Risk of Fracture in Bulgaria Simeon MonovRodina NestorovaTzvetanka Petranova Original Research Open access 08 February 2021 Pages: 443 - 455
Ultrasound Ulnar Nerve Measurement in a Healthy Population Hoel LetissierGuillaume DardenneSandrine Jousse-Joulin Original Research Open access 04 February 2021 Pages: 457 - 466
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry Dimitrios A. PappasTaylor BlachleyJoel M. Kremer Original Research Open access 25 February 2021 Pages: 467 - 481
Real-World Treatment Persistence with Biologic Disease-Modifying Antirheumatic Drugs Among German Patients with Psoriatic Arthritis—A Retrospective Database Study Philipp SewerinKathrin BorchertJörg Mahlich Original Research Open access 21 February 2021 Pages: 483 - 497
Human Osteochondral Explants: Reliable Biomimetic Models to Investigate Disease Mechanisms and Develop Personalized Treatments for Osteoarthritis Evelyn HoutmanMarcella van HoolwerffIngrid Meulenbelt Original Research Open access 20 February 2021 Pages: 499 - 515
Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population Muhan ZhengAiju LouWeinan Lai Original Research Open access 14 February 2021 Pages: 517 - 527
Treatment Patterns, Disease Burden, and Outcomes in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica: A Real-World, Electronic Health Record-Based Study of Patients in Clinical Practice Gary CraigKeith KnappMargaret Michalska Original Research Open access 26 February 2021 Pages: 529 - 539
Patient Experience With Fatigue and Qualitative Interview-Based Evidence of Content Validation of The FACIT-Fatigue in Systemic Lupus Erythematosus Kimberly RaymondJosephine ParkMichelle K. White Original Research Open access 09 March 2021 Pages: 541 - 554
Characteristics Associated with the Occurrence and Development of Acute Anterior Uveitis, Inflammatory Bowel Disease, and Psoriasis in Patients with Ankylosing Spondylitis: Data from the Chinese Ankylosing Spondylitis Prospective Imaging Cohort Siliang ManXiaojian JiFeng Huang Original Research Open access 11 March 2021 Pages: 555 - 571
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus Anca D. AskanaseGeorge J. WanRichard A. Furie Original Research Open access 09 March 2021 Pages: 573 - 584
Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study Yiyi WangLi DingWei Li Original Research Open access 05 March 2021 Pages: 585 - 597
Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US Alison WaltonJim PaikJustin K. Owensby Brief Report Open access 23 January 2021 Pages: 599 - 607
A Novel Qualitative Study Assessing Patient-Reported Outcome Measures Among People Living with Psoriatic Arthritis or Ankylosing Spondylitis Soumya D. ChakravartyJill AbellAna-Maria Orbai Brief Report Open access 22 February 2021 Pages: 609 - 620
Sjögren's Syndrome Associated With Thrombotic Thrombocytopenic Purpura: A Case-Based Review Jozélio F. CarvalhoYehuda Shoenfeld Case Report Open access 14 December 2020 Pages: 621 - 629
Sjögren’s Syndrome Associated with Chikungunya Infection: A Case Report Jozélio Freire de CarvalhoDarja KanducYehuda Shoenfeld Case Report Open access 01 February 2021 Pages: 631 - 637
